本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BridgeBio Pharma, Inc.

69.20
+0.89001.30%
成交量:58.87萬
成交額:4,124.33萬
市值:134.15億
市盈率:-16.54
高:71.50
開:70.49
低:68.36
收:68.31
52周最高:84.94
52周最低:28.33
股本:1.94億
流通股本:1.51億
量比:1.90
換手率:0.39%
股息:- -
股息率:- -
每股收益(TTM):-4.1844
每股收益(LYR):-2.8793
淨資產收益率:-1789.67%
總資產收益率:-43.47%
市淨率:-6.94
市盈率(LYR):-24.03

資料載入中...

2026/02/24

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/24

重要事件披露

Form 8-K - Current report
2026/02/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/13

重要事件披露

Form 8-K - Current report
2026/01/21

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2026/01/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/29

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]